ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Ospedale San Raffaele at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Ospedale San Raffaele brings 5 presentations to ACR Convergence 2026 in Orlando. Its program centres on rare rheumatic disease, including IgG4-related disease, VEXAS syndrome treated with momelotinib, and predictors of interstitial lung disease in systemic sclerosis. It also covers infection risk with long-term inebilizumab.

OrganizationACR Convergence 2026 Attendance
Hospitals and health systems
A research and teaching hospital in Milan.
Talk
Mon Nov 9
10:00am–10:30am
Part of IgG4-Related Disease: Mechanisms, Therapeutics, and Outcomes
Epidemiology and Malignancy Risk in IgG4-Related Disease: From Genetics to Population Studies
W304A-H
Rare and other diseases
Industry
Tue Nov 10
5:30pm–7:30pm
IgG4-RD in Focus: From Disease Burden to Emerging Clinical Evidence
Hyatt Regency Orlando, Windermere Ballroom Y
Rare and other diseases · Supported by Zenas BioPharma · with Stanford University, Massachusetts General Hospital

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ospedale San Raffaele

Tell us what you sell and we’ll find the people at Ospedale San Raffaele most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction